Shahin Isha MBBS, MD , Prasanth Balasubramanian MBBS, MD , Lekhya Raavi MBBS, MD , Abby J. Hanson BS , Anna Jenkins BS , Parthkumar Satashia MBBS, MD , Arvind Balavenkataraman MBBS, MD , Iván A. Huespe MD , Aysun Tekin MD , Vikas Bansal MBBS, MPH , Sean M. Caples DO, MS , Syed Anjum Khan MD , Nitesh K. Jain MBBS , Abigail T. LaNou MD , Rahul Kashyap MBBS, MBA , Rodrigo Cartin-Ceba MD , Bhavesh M. Patel MD , Houssam Farres MD , Scott A. Helgeson MD , Ricardo Diaz Milian MD , Devang K. Sanghavi MBBS, MD
{"title":"Association of estimated plasma volume with new onset acute kidney injury in hospitalized COVID-19 patients","authors":"Shahin Isha MBBS, MD , Prasanth Balasubramanian MBBS, MD , Lekhya Raavi MBBS, MD , Abby J. Hanson BS , Anna Jenkins BS , Parthkumar Satashia MBBS, MD , Arvind Balavenkataraman MBBS, MD , Iván A. Huespe MD , Aysun Tekin MD , Vikas Bansal MBBS, MPH , Sean M. Caples DO, MS , Syed Anjum Khan MD , Nitesh K. Jain MBBS , Abigail T. LaNou MD , Rahul Kashyap MBBS, MBA , Rodrigo Cartin-Ceba MD , Bhavesh M. Patel MD , Houssam Farres MD , Scott A. Helgeson MD , Ricardo Diaz Milian MD , Devang K. Sanghavi MBBS, MD","doi":"10.1016/j.amjms.2024.07.018","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>To explore the association of estimated plasma volume (ePV) and plasma volume status (PVS) as surrogates of volume status with new-onset AKI and in-hospital mortality among hospitalized COVID-19 patients.</div></div><div><h3>Materials and methods</h3><div>We performed a retrospective multi-center study on COVID-19-related ARDS patients who were admitted to the Mayo Clinic Enterprise health system. Plasma volume was calculated using the formulae for ePV and PVS, and longitudinal analysis was performed to find the association of ePV and PVS with new-onset AKI during hospitalization as the primary outcome and in-hospital mortality as a secondary outcome.</div></div><div><h3>Results</h3><div>Our analysis included 7616 COVID-19 patients with new-onset AKI occurring in 1365 (17.9%) and a mortality rate of 25.96% among them. A longitudinal multilevel multivariate analysis showed both ePV (OR 1.162; 95% CI 1.048–1.288, <em>p</em>=0.004) and PVS (OR 1.032; 95% CI 1.012–1.050, <em>p</em>=0.001) were independent predictors of new onset AKI. Higher PVS was independently associated with increased in-hospital mortality (OR 1.038, 95% CI 1.007–1.070, <em>p</em>=0.017), but not ePV (OR 0.868, 95% CI 0.740–1.018, <em>p</em>=0.082).</div></div><div><h3>Conclusion</h3><div>A higher PVS correlated with a higher incidence of new-onset AKI and worse outcomes in our cohort of hospitalized COVID-19 patients. Further large-scale and prospective studies are needed to understand its utility.</div></div>","PeriodicalId":55526,"journal":{"name":"American Journal of the Medical Sciences","volume":"368 6","pages":"Pages 589-599"},"PeriodicalIF":2.3000,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of the Medical Sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0002962924013533","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose
To explore the association of estimated plasma volume (ePV) and plasma volume status (PVS) as surrogates of volume status with new-onset AKI and in-hospital mortality among hospitalized COVID-19 patients.
Materials and methods
We performed a retrospective multi-center study on COVID-19-related ARDS patients who were admitted to the Mayo Clinic Enterprise health system. Plasma volume was calculated using the formulae for ePV and PVS, and longitudinal analysis was performed to find the association of ePV and PVS with new-onset AKI during hospitalization as the primary outcome and in-hospital mortality as a secondary outcome.
Results
Our analysis included 7616 COVID-19 patients with new-onset AKI occurring in 1365 (17.9%) and a mortality rate of 25.96% among them. A longitudinal multilevel multivariate analysis showed both ePV (OR 1.162; 95% CI 1.048–1.288, p=0.004) and PVS (OR 1.032; 95% CI 1.012–1.050, p=0.001) were independent predictors of new onset AKI. Higher PVS was independently associated with increased in-hospital mortality (OR 1.038, 95% CI 1.007–1.070, p=0.017), but not ePV (OR 0.868, 95% CI 0.740–1.018, p=0.082).
Conclusion
A higher PVS correlated with a higher incidence of new-onset AKI and worse outcomes in our cohort of hospitalized COVID-19 patients. Further large-scale and prospective studies are needed to understand its utility.
期刊介绍:
The American Journal of The Medical Sciences (AJMS), founded in 1820, is the 2nd oldest medical journal in the United States. The AJMS is the official journal of the Southern Society for Clinical Investigation (SSCI). The SSCI is dedicated to the advancement of medical research and the exchange of knowledge, information and ideas. Its members are committed to mentoring future generations of medical investigators and promoting careers in academic medicine. The AJMS publishes, on a monthly basis, peer-reviewed articles in the field of internal medicine and its subspecialties, which include:
Original clinical and basic science investigations
Review articles
Online Images in the Medical Sciences
Special Features Include:
Patient-Centered Focused Reviews
History of Medicine
The Science of Medical Education.